ProCE Banner Activity

Factors Associated With Virologic Failure With Long-Acting ART: Perspectives From Canada

Clinical Thought
In expanded multivariable analyses from ATLAS, ATLAS-2M, and FLAIR of people with HIV receiving long-acting cabotegravir plus rilpivirine, factors most predictive of confirmed virologic failure were preexisting rilpivirine resistance-associated mutations and HIV-1 subtype A6/A1.

Released: November 22, 2022

Expiration: November 21, 2023

Share

Faculty

Darrell H. S. Tan

Darrell H. S. Tan, MD, FRCPC, PhD

Associate Professor
Division of Infectious Diseases
University of Toronto
Clinician-Scientist
Division of Infectious Diseases
St. Michaels Hospital
Toronto, Canada

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Darrell H. S. Tan, MD, FRCPC, PhD

Associate Professor
Division of Infectious Diseases
University of Toronto
Clinician-Scientist
Division of Infectious Diseases
St. Michaels Hospital
Toronto, Canada

Darrell H. S. Tan, MD, FRCPC, PhD: researcher: AbbVie, Gilead Sciences, GlaxoSmithKline.